Gastrointestinal dysfunction in the critically ill: a systematic scoping review and research agenda proposed by the Section of Metabolism, Endocrinology and Nutrition of the European Society of Intensive Care MedicineAdam M. Deane, Jan Wernerman, Carina Benstoem et al.|Critical Care|2020Cited by 212
Efficacy and Safety of Vilobelimab (IFX-1), a Novel Monoclonal Anti-C5a Antibody, in Patients With Early Severe Sepsis or Septic Shock—A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase IIa Trial (SCIENS Study)Michael Bauer, A. Weyland, Gernot Marx et al.|Critical Care Explorations|2021Cited by 36
Randomisierte kontrollierte multizentrische Studie zur Albuminersatztherapie im septischen Schock (ARISS)Yasser Sakr, Uwe Lodes, Luciano Gattinoni et al.|Der Anaesthesist|2021Cited by 0